Skip to main content
. 2023 May 17;82(7):611–619. doi: 10.1093/jnen/nlad035

Table 5.

Recommendations for the application of phosphorylated TDP-43 immunohistochemistry to the condensed protocol

  • All patients with a clinical history of dementia

  • All patients with hippocampal sclerosis (HS)*

  • All patients ≥80 years old

*

If hippocampal sclerosis (HS) is identified unilaterally, pTDP-43 should be performed on the side with HS.